Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Radiotherapy 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2lenvatinib 1Specimen Handling 1Sorafenib 1Platinum 1Photochemotherapy 1Oxycodone 1NUC-1031 1Ketorolac 1Ketamine 1Ipilimumab 1Gemcitabine 1Folfox protocol 1Cisplatin 1CTLA-4 Antigen 1Biopsy 1Acetaminophen 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Suspended × NUC-1031 × Clear all
NCT03610100 2019-10-29

ACELARATE

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase 2/3 Suspended
328 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡